Document Details
Form
Filing Date
Apr 3, 2024
Document Date
Mar 28, 2024
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Inozyme Pharma, Inc.
Issuer
INOZYME PHARMA, INC.
Filer
WINTON MATTHEW